Evidence map›Paper›PMID 38808199›Full record

ArticleClinical case reports2024

An uncommon presentation of autoimmune polyglandular syndrome type 1 (APS-1)-A case report.

Ali M Alrufaidi, Mohammed Mosa Alnashery, Ageel Ahmad Alghanimi, Rash Elamin Ahmed Elmansor, Ramy Mohamed Ghazy

Abstract readCase Reports
In one paragraph

Article in Clinical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ali M AlrufaidiEndocrinology Department Al-Qunfudhdh General Hospital Makkah Saudi Arabia.
Mohammed Mosa AlnasheryEndocrinology Department Al-Qunfudhdh General Hospital Makkah Saudi Arabia.
Ageel Ahmad AlghanimiEndocrinology Department Al-Qunfudhdh General Hospital Makkah Saudi Arabia.
Rash Elamin Ahmed ElmansorEndocrinology Department Al-Qunfudhdh General Hospital Makkah Saudi Arabia.
Ramy Mohamed GhazyFamily and Community Medicine Department College of Medicine, King Khalid University Abha Saudi Arabia.ORCID https://orcid.org/0000-0001-7611-706X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Key Clinical Message: Autoimmune polyglandular syndrome type 1 (APS-1) is a rare disorder defined by the presence of at least two of the following conditions: chronic mucocutaneous candidiasis (CMC), chronic hypoparathyroidism, and Addison's syndrome. Despite the lack of CMC and autoimmune history, APS-1 can be diagnosed using genetic testing. We present the case of a 28-year-old female patient with a history of hypocalcemia due to hypoparathyroidism since the age of 2 years. She presented to the endocrine clinic with hypogonadism, primary amenorrhea, and primary ovarian insufficiency. Addison's disease was eventually diagnosed, despite a negative Synacthen test. The adrenal crisis required intravenous hydrocortisone therapy. No CMC was documented, and there was no family history of such conditions. The diagnosis of APS-1 was confirmed by genetic testing, revealing homozygous pathogenic variants of the autoimmune regulator gene. Management included oral calcium and calcitriol and oral hydrocortisone and fludrocortisone for Addison's disease. Hormonal induction of secondary sexual characteristics was initiated. The patient received combined oral estrogen and progesterone pills. This case highlights the critical significance of early recognition, thorough evaluation, and tailored treatment for patients with APS-1 to enhance their quality of life and mitigate potentially life-threatening complications. This underscores the importance of screening for associated minor autoimmune diseases as part of a holistic approach to care.

Indexed as

AIRE gene mutationautoimmune diseasesendocrine disordershormonal replacement therapypolyglandular autoimmune syndrome type 1primary ovarian insufficiency

Identifiers

PMID38808199
PMCPMC11130226

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.